Your Article Summary
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Vascular Health and Risk Management, 05/11/09
Reboldi G et al. - Angiotensin converting enzyme (ACE) inhibitor plus diuretic combination therapy improves blood pressure control, counterbalances renin-angiotensin system activation due to diuretic therapy and reduces the risk of electrolyte alterations, obtaining at the same time synergistic antiproteinuric effects. ACE inhibitor plus calcium channel blocker provides a significant additive effect on blood pressure reduction, may have favorable metabolic effects and synergistically reduce proteinuria and the rate of decline in glomerular filtration rate, as evidenced by the GUARD trial. Finally, the recently published ACCOMPLISH trial showed that an ACE inhibitor/calcium channel blocker combination may be particularly useful in reducing cardiovascular outcomes in high-risk patients. The present review will focus on different ACE inhibitor combinations in the treatment of patients with type 2 diabetes mellitus and hypertension, in the light of recent clinical trials, including GUARD and ACCOMPLISH.
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 70%
Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension. Inter-American Society of Hypertension
Hypertension, 10/29/09
Relevance Score: 69%
Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension
Journal of Human Hypertension, 11/04/09
Relevance Score: 68%
Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant
Nutrition, Metabolism & Cardiovascular Diseases, 10/20/09
Relevance Score: 68%
Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Resorption and elimination kinetics of benzoic acid during chemical necrectomy in deep burns
Scandinavian Journal of Clinical and Laboratory Investigation, 12/19/09
Dienogest: a new therapeutic agent for the treatment of endometriosis *TEST*
Women's Health, 12/17/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Characteristics and reference ranges of Insulin-Like Growth Factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians
Scandinavian Journal of Clinical and Laboratory Investigation, 12/19/09
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
Scandinavian Journal of Clinical and Laboratory Investigation, 12/19/09
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/17/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
GNB3 C825T Polymorphism and Elevated Blood Pressure
International Journal of Sports Medicine, 12/19/09
Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/17/09
Infarct Remodeling Process During Long-term Follow-up After Reperfused Acute Myocardial Infarction
The American Journal of the Medical Sciences, 12/17/09

See Latest Articles